Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 385M | 582M | 490M | 504M |
Cost of revenue | 143M | 222M | 187M | 180M |
Gross profit | 242M | 360M | 303M | 324M |
Operating expense | ||||
Research & development | 43M | 51M | 41M | 45M |
Selling general and admin | 203M | 202M | 194M | 203M |
Other operating expenses | 8M | — | 3M | -1M |
Operating income | -12M | 175M | 65M | 77M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 4M | 158M | 61M | 68M |
Tax provision | 0 | -1M | 16M | 20M |
Net income | 4M | 159M | 45M | 48M |
Basic EPS | 0.1 | 2.0 | 0.6 | 0.6 |
Diluted EPS | 0.1 | 2.0 | 0.6 | 0.6 |
Basic average shares | 80.0M | 80.0M | 80.0M | 80.0M |
Diluted average shares | 80.2M | 80.2M | 80.1M | 80.0M |
EBITDA | 28M | 222M | 111M | 123M |
Net income from continuing op. | 4M | 158M | 61M | 68M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |